# Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVI

> **NCT05862883** · PHASE2 · COMPLETED · sponsor: **Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan** · enrollment: 301 (actual)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

- **DRUG:** Rutan 25 mg
- **OTHER:** Control group

## Key facts

- **NCT ID:** NCT05862883
- **Lead sponsor:** Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 301 (ACTUAL)
- **Last updated:** 2023-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05862883

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05862883, "Studying the Efficiency of the Natural Preparation Rutan in Children in the Treatment of COVID-19, ARVI". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05862883. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*